Professional Society Guidelines

Use of CGM in Pediatrics – A Consensus Statement

You are here

Consensus Statement, Pediatric Diabetes (2012)

This consensus statement has been developed by a world-wide expert panel of pediatric endocrinologists and represents the clinical guidance of the use of continuous glucose monitoring (CGM) from the European Society for Pediatric Endocrinology, the Pediatric Endocrine Society and the International Society for Pediatric and Adolescent Diabetes. Use of real-time CGM provides the following benefits:

  • Improved overnight control with hypoglycemia alarms
  • Enhanced understanding of diabetes management teaching
  • Improved daytime bolus dosing with trend arrows and hyper- and hypoglycemia alarms for real-time adjustements
  • Improved management of acute illnesses

Source: Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamboralne W, Battelino T and Consensus Forum Participants. Pediatric Diabetes, 2012.

View the article.

More Professional Society Guidelines

The Endocrine Society recently published new diabetes treatment guidelines,1,2 which may help providers to guide patients on adjusting pre-meal and ≥3 hour post-meal insulin doses using Dexcom G5 Mobile CGM trend arrows. Below, find...

Guidelines to Improve Glucose Control Using the Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System for Healthcare Professionals.

This section from the American Diabetes Association (ADA) Standards of Medical Care for Diabetes includes information regarding usage of continuous glucose monitoring (CGM).

View the article.